Report of the task force on designing clinical trials in early (predementia) AD

Por Aisen, P.S., Andrieu, S., Sampaio, C., Carrillo, M., Khachaturian, Z.S., Dubois, B., Feldman, H.H., Petersen, R.C., Siemers, E., Doody, R.S., Hendrix, S.B., Grundman, M., Schneider, L.S., Schindler, R.J., Salmon, E., Potter, W.Z., Thomas, R.G., Salmon, D., Donohue, M., Bednar, M.M., Touchon, J., Vellas, B.
Publicado em 2011

The Road Ahead to Cure Alzheimer’s Disease: Development of Biological Markers and Neuroimaging Methods for Prevention Trials Across all Stages and Target Populations

Por Cavedo, E., Lista, S., Khachaturian, Z., Aisen, P., Amouyel, P., Herholz, K., Jack, C.R., Sperling, R., Cummings, J., Blennow, K., O’Bryant, S., Frisoni, G.B., Khachaturian, A., Kivipelto, M., Klunk, W., Broich, K., Andrieu, S., de Schotten, M. Thiebaut, Mangin, J.-F., Lammertsma, A.A., Johnson, K., Teipel, S., Drzezga, A., Bokde, A., Colliot, O., Bakardjian, H., Zetterberg, H., Dubois, B., Vellas, B., Schneider, L.S., Hampel, H.
Publicado no J Prev Alzheimers Dis (2014)